PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $790,000 | +12.1% | 250,900 | +3.6% | 0.00% | 0.0% |
Q2 2020 | $705,000 | +12.4% | 242,200 | +8.9% | 0.00% | 0.0% |
Q1 2020 | $627,000 | -13.2% | 222,400 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $722,000 | +47.6% | 222,400 | -1.8% | 0.00% | 0.0% |
Q3 2019 | $489,000 | -42.7% | 226,500 | -16.6% | 0.00% | 0.0% |
Q2 2019 | $853,000 | -13.8% | 271,700 | +2.1% | 0.00% | 0.0% |
Q1 2019 | $990,000 | +32.7% | 266,100 | +3.5% | 0.00% | 0.0% |
Q4 2018 | $746,000 | +5.4% | 257,100 | -4.5% | 0.00% | 0.0% |
Q3 2018 | $708,000 | +12.4% | 269,200 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $630,000 | -20.4% | 269,200 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $791,000 | +7.2% | 269,200 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $738,000 | -11.9% | 269,200 | +8.9% | 0.00% | 0.0% |
Q3 2017 | $838,000 | +37.2% | 247,200 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $611,000 | +8.9% | 247,200 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $561,000 | +7.1% | 247,200 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $524,000 | -36.7% | 247,200 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $828,000 | +6.7% | 247,200 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $776,000 | -2.1% | 247,200 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $793,000 | +14.3% | 247,200 | +26.1% | 0.00% | -50.0% |
Q4 2015 | $694,000 | -29.6% | 196,100 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $986,000 | -9.2% | 196,100 | +16.1% | 0.00% | 0.0% |
Q2 2015 | $1,086,000 | -7.0% | 168,900 | +1.7% | 0.00% | 0.0% |
Q1 2015 | $1,168,000 | -6.6% | 166,000 | +2.3% | 0.00% | -40.0% |
Q4 2014 | $1,251,000 | +5.7% | 162,200 | +2.5% | 0.01% | 0.0% |
Q3 2014 | $1,183,000 | -24.2% | 158,300 | -1.8% | 0.01% | -16.7% |
Q2 2014 | $1,560,000 | +23.8% | 161,200 | +6.3% | 0.01% | +20.0% |
Q1 2014 | $1,260,000 | +28.4% | 151,600 | +30.5% | 0.01% | +25.0% |
Q4 2013 | $981,000 | +5.9% | 116,200 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $926,000 | -2.3% | 116,200 | -5.4% | 0.00% | 0.0% |
Q2 2013 | $948,000 | – | 122,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |